A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)
Clinical trial NCT00473382 · COMPLETED
Trial details
- NCT number
- NCT00473382
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2011-01-01
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.